Brief: Mateon says William D. Schwieterman appointed chairman of the board
22/08/2016 14:04
Aug 22 (Reuters) - Mateon Therapeutics Inc MATN.O
* Says William D. Schwieterman appointed chairman of the
board
* Says Frederick Driscoll tendered his resignation from
board of directors of Mateon Therapeutics, Inc.
Source text for Eikon: (http://bit.ly/2bYxYEG)
Further company coverage: MATN.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Oncotelic Therapeutics
See all newsBrief: Oncotelic Therapeutics Emerging As Leader With New Independent JV Valuation
Brief: Oncotelic Therapeutics - JV Is Preparing For A Potential Initial Public Offering On The Hong Kong Stock Exchange In Late 2026
Brief: Oncotelic Therapeutics To Sell Its Necroptosis Cancer Therapy Assets To Mosaic Immunoengineering
Brief: Oncotelic Announces Initiation Of Clinical Study In Non-Small Lung Cell Cancer
Brief: Oncotelic Initiates Clinical Trials Evaluating Ot-101 Against Pediatric Gliomas